Lead Sponsor

Chieko Hamada

Age

20 - 80 years

Sex

ALL

Healthy Volunteers

No

•patients under hemodialysis
•patients with hypercholesterolemia as defined by any of following parameters:
•* LDL-C ≧ 100 mg / dL
•* TC ≧ 180 mg / dL
•* patients required cholesterol-lowering treatment by investigators.
•patients aged 20-75 years
•patients with written consent by their own volition after being provided sufficient explanation for the participation into this clinical trial

•patients taking statins or fibrates
•patients enrolled to the other trials using contraindication drugs of pitavastatin
•patients who had acute myocardial infarction within six months before the day of the agreement acquisition
•patients scheduled PCI and CABG within six months after the day of the agreement acquisition
•Patients who had diagnosis or doubt of malignant tumor
•patients corresponded to "Contraindications" of pitavastatin
•Familial hypercholesterolemia patients
•patients judged ineligible by investigators

Related studies

NCT07669168 · Health Services Accessibility, Rural Health, and more

NCT07136012 · Cardiovascular Disease

NCT07256249 · Cardiovascular Diseases

NCT06675552 · Heart Disease, Heart Failure, and more

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)